Noven Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of prescription transdermal products and transdermal drug delivery technologies. It operates through two segments, Noven Transdermals and Noven Therapeutics. Noven Pharmaceuticals markets its products in the United States, Canada, and Japan, as well as in Europe. The company was founded in 1987 and is headquartered in Miami, Florida. Noven was acquired by Hisamitsu in August 2009

Company was acquired by Hisamitsu Pharmaceutical Co. Inc.

Acquired Companies: JDS Pharmaceuticals